Inflamgo
Natural health product licensed in Canada
- Other names
- Joint EZE Liquid
- Licence holder
- Alcrea Health
- NPN or DIN-HM
- 80030589
- Status
- Inactive licence
- Licence date
- 19 March 2012
- Revision date
- 3 July 2012
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Salix alba Source : Écorce | 2 mg | Not calculated |
| Méthylsulfonylméthane Source : Synthétique | 100 mg | Not calculated |
| Niacinamide Source : Niacinamide | 35 mg | Not calculated |
| Sulfate de chondroïtine Source : Cartilage de porc | 400 mg | Not calculated |
Non-medicinal ingredients
Acide DL-malique, Eau, Sorbate de potassium, Saveur, Feuille de stevia rebaudiana
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | maximum: 1.5 Cuillère à thé | 1 day |
Uses authorised in Canada
Utilisé en phytothérapie pour aider à soulager la douleur articulaire associée à l'arthrose.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un praticien de soins de santé si les symptômes persistent ou s'aggravent. Ne pas utiliser si vous êtes enceinte ou si vous allaitez. Ne pas utiliser si vous êtes allergiques à l'acide acétyl salicylique (AAS) ou à d'autres salicylates. Consulter un praticien de soins de santé avant d'en faire l'usage si vous suivez un régime basse teneur en protéines ou si vous avez des réactions indésirables gastro-intestinales.
- Effets indésirables connus
Certaines personnes pourraient souffrir de légers ballonnements gastro-intestinaux, de constipation ou d'indigestion.
Source
Official Health Canada record, licence 80030589
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2012. Photograph the packaging to check whether it has changed. Photograph the packaging